NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, News, & Analysis

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Allscripts Healthcare Solutions announced that its board has approved a stock repurchase plan on Thursday, August 2nd 2018, which allows the company to repurchase $250,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization allows the company to repurchase up to 11.3% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's board of directors believes its shares are undervalued.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) released its quarterly earnings results on Thursday, February, 21st. The software maker reported $0.20 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.21 by $0.01. The software maker had revenue of $538 million for the quarter, compared to analysts' expectations of $565.52 million. Allscripts Healthcare Solutions had a net margin of 18.15% and a return on equity of 7.74%. The business's revenue was down 1.6% on a year-over-year basis. During the same period last year, the firm posted $0.18 EPS. View Allscripts Healthcare Solutions' Earnings History.

Allscripts Healthcare Solutions is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for Allscripts Healthcare Solutions.

Allscripts Healthcare Solutions will be holding an earnings conference call on Thursday, May 2nd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 8772697756.

Allscripts Healthcare Solutions updated its FY19 earnings guidance on Thursday, February, 21st. The company provided earnings per share (EPS) guidance of $0.65-$0.70 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.81. Allscripts Healthcare Solutions also updated its FY 2019 guidance to $0.65-0.70 EPS.

10 Wall Street analysts have issued 12 month price targets for Allscripts Healthcare Solutions' shares. Their predictions range from $12.00 to $18.00. On average, they anticipate Allscripts Healthcare Solutions' share price to reach $14.3478 in the next year. This suggests a possible upside of 50.2% from the stock's current price. View Analyst Price Targets for Allscripts Healthcare Solutions.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 5 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Allscripts Healthcare Solutions.

Media coverage about MDRX stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Allscripts Healthcare Solutions earned a news impact score of 1.1 on InfoTrie's scale. They also assigned media coverage about the software maker a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the next few days.

Allscripts Healthcare Solutions saw a increase in short interest during the month of April. As of April 15th, there was short interest totalling 20,675,861 shares, an increase of 8.4% from the March 29th total of 19,078,421 shares. Based on an average daily volume of 1,566,012 shares, the short-interest ratio is currently 13.2 days. Currently, 12.4% of the company's shares are short sold. View Allscripts Healthcare Solutions' Current Options Chain.

Some companies that are related to Allscripts Healthcare Solutions include Caci International (CACI), Science Applications International (SAIC), Verint Systems (VRNT), NetScout Systems (NTCT), Scientific Games (SGMS), Ebix (EBIX), Nextgen Healthcare (NXGN), Sykes Enterprises (SYKE), Onespan (OSPN), Tufin Software Technologies (TUFN), Unisys (UIS), Ribbon Communications (RBBN), KEYW (KEYW), Agilysys (AGYS) and Pareteum (TEUM).

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Starbucks (SBUX), Electronic Arts (EA), Micron Technology (MU), Walgreens Boots Alliance (WBA), Bausch Health Companies (BHC), Twitter (TWTR), Activision Blizzard (ATVI) and Cypress Semiconductor (CY).

Allscripts Healthcare Solutions' stock is owned by a number of of retail and institutional investors. Top institutional investors include Peregrine Capital Management LLC (0.78%), Hennessy Advisors Inc. (0.69%), Retirement Systems of Alabama (0.13%), Dalton Greiner Hartman Maher & Co. (0.13%), Meeder Asset Management Inc. (0.06%) and First Quadrant L P CA (0.03%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, James Hewitt, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View Institutional Ownership Trends for Allscripts Healthcare Solutions.

MDRX stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., BNP Paribas Arbitrage SA, Hennessy Advisors Inc., First Quadrant L P CA, Creative Planning, Retirement Systems of Alabama and Oppenheimer Asset Management Inc.. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, Dennis Olis and Richard J Poulton. View Insider Buying and Selling for Allscripts Healthcare Solutions.

MDRX stock was acquired by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Meeder Asset Management Inc., Sciencast Management LP and Virtu Financial LLC. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black and Yancey L Spruill. View Insider Buying and Selling for Allscripts Healthcare Solutions.

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MDRX stock can currently be purchased for approximately $9.55.

Allscripts Healthcare Solutions has a market capitalization of $1.59 billion and generates $1.75 billion in revenue each year. The software maker earns $412.33 million in net income (profit) each year or $0.55 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,500 workers across the globe.

The official website for Allscripts Healthcare Solutions is http://www.allscripts.com.

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]